Back to GetFilings.com



Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2003

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     .

Commission file number 000-23783


MICROMUSE INC.

(Exact name of registrant as specified in its charter)


 

  DELAWARE
(State or other jurisdiction of
incorporation or organization)
  94-3288385
(IRS Employer Identification No.)
 
 

139 TOWNSEND STREET
SAN FRANCISCO, CALIFORNIA 94107
(415) 538-9090
(Address, including ZIP code, and telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant is an accelerated filer (as defined in rule 12b-2 of the Exchange Act).

Yes o No x

75,767,894 shares of Common Stock, $0.01 par value, were outstanding as of April 30, 2003





Table of Contents

MICROMUSE INC.

TABLE OF CONTENTS

 

 

 

 

 

 

Page

 

 

 

 

 

 

Part I

 

Financial Information

 

 

 

 

 

 

 

 

 

Item 1.

 

Condensed Consolidated Financial Statements (Unaudited):

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2003 and September 30, 2002

3

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2003 and 2002

4

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2003 and 2002

5

 

 

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

6

 

 

 

 

 

 

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

 

 

 

 

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risk

34

 

 

 

 

 

 

 

 

Item 4.

 

Controls and Procedures

35

 

 

 

 

 

 

Part II

 

Other Information

 

 

 

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

36

 

 

 

 

 

 

 

 

Item 2.

 

Changes in Securities and Use of Proceeds

36

 

 

 

 

 

 

 

 

Item 3.

 

Defaults upon Senior Securities

36

 

 

 

 

 

 

 

 

Item 4.

 

Submission of Matters to a Vote of Security Holders

36

 

 

 

 

 

 

 

 

Item 5.

 

Other Information

36

 

 

 

 

 

 

 

 

Item 6.

 

Exhibits and Reports on Form 8-K

37


Signature

38

 

 

Certifications

39



2


Table of Contents

MICROMUSE INC.

CONDENSED CONSOLIDATED BALANCE SHEET
(In thousands, except per share data)
(Unaudited)

 

 

 

March 31,
2003

 

September 30,
2002

 

 

 


 


 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

117,268

 

$

117,218

 

Short-term investments

 

 

48,100

 

 

42,126

 

Billed receivables, net

 

 

8,846

 

 

18,386

 

Prepaid expenses and other current assets

 

 

6,112

 

 

5,760

 

 

 



 



 

Total current assets

 

 

180,326

 

 

183,490

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

6,776

 

 

9,534

 

Long-term investments

 

 

39,059

 

 

28,293

 

Goodwill and other intangible assets, net

 

 

40,094

 

 

40,666

 

 

 



 



 

 

 

$

266,255

 

$

261,983

 

 

 



 



 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

4,623

 

$

2,374

 

Accrued expenses

 

 

19,783

 

 

25,205

 

Income taxes payable

 

 

6,693

 

 

6,652

 

Deferred revenue

 

 

48,349

 

 

36,524

 

 

 



 



 

Total current liabilities

 

 

79,448

 

 

70,755

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

 

Preferred stock; $0.01 par value; 5,000 shares authorized no shares issued and outstanding

 

 

 

 

 

Common stock; $0.01 par value; 200,000 shares authorized; 76,008 and 75,194 shares outstanding as of March 31, 2003 and September 30, 2002, respectively

 

 

760

 

 

752

 

Additional paid-in capital

 

 

198,930

 

 

196,048

 

Treasury stock

 

 

(2,657

)

 

(2,657

)

Accumulated other comprehensive loss

 

 

(1,876

)

 

(899

)

Accumulated deficit

 

 

(8,350

)

 

(2,016

)

 

 



 



 

Total stockholders’ equity

 

 

186,807

 

 

191,228

 

 

 



 



 

 

 

$

266,255

 

$

261,983

 

 

 



 



 


See accompanying notes to the condensed consolidated financial statements


3


Table of Contents

MICROMUSE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

 

 

 

Three months ended
March 31,

 

Six months ended
March 31,

 

 

 


 


 

 

 

2003

 

2002

 

2003

 

2002

 

 

 


 


 


 


 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

License

 

$

18,598

 

$

24,639

 

$

32,021

 

$

47,855

 

Maintenance and services

 

 

13,437

 

 

14,399

 

 

27,111

 

 

31,230

 

 

 



 



 



 



 

Total revenues

 

 

32,035

 

 

39,038

 

 

59,132

 

 

79,085

 

 

 



 



 



 



 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

License

 

 

1,748

 

 

1,506

 

 

2,824

 

 

3,101

 

Maintenance and services

 

 

2,949

 

 

4,605

 

 

6,238

 

 

9,813

 

 

 



 



 



 



 

Total cost of revenues

 

 

4,697

 

 

6,111

 

 

9,062

 

 

12,914

 

 

 



 



 



 



 

Gross profit

 

 

27,338

 

 

32,927

 

 

50,070

 

 

66,171

 

 

 



 



 



 



 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

14,478

 

 

18,092

 

 

28,920

 

 

36,177

 

Research and development

 

 

7,096

 

 

8,060

 

 

14,517

 

 

15,630

 

General and administrative

 

 

4,021

 

 

4,079

 

 

8,087

 

 

9,017

 

Amortization of goodwill and other intangible assets

 

 

1,469

 

 

2,767

 

 

3,021

 

 

5,534

 

Purchased in process research and development

 

 

 

 

 

 

142

 

 

 

Restructuring costs

 

 

 

 

 

 

3,329

 

 

 

Executive recruiting costs

 

 

 

 

 

 

 

 

449

 

 

 



 



 



 



 

Total operating expenses

 

 

27,064

 

 

32,998

 

 

58,016

 

 

66,807

 

 

 



 



 



 



 

Income (loss) from operations

 

 

274

 

 

(71

)

 

(7,946

)

 

(636

)

Other income, net

 

 

1,263

 

 

1,305

 

 

2,643

 

 

2,913

 

 

 



 



 



 



 

Income (loss) before income taxes

 

 

1,537

 

 

1,234

 

 

(5,303

)

 

2,277

 

Income tax provision

 

 

546

 

 

815

 

 

1,031

 

 

1,242

 

 

 



 



 



 



 

Net income (loss)

 

$

991

 

$

419

 

$

(6,334

)

$

1,035

 

 

 



 



 



 



 

Per share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income (loss)

 

$

0.01